Kiek dividendų moka Alfresa Holdings 2024?
Pagal paskutinę informaciją nuo gruodis 2024, Alfresa Holdings per paskutinius 12 mėnesių mokėjo bendrą dividendą, kuris sudarė 36,00 JPY už akciją. Esant dabartiniam Alfresa Holdings kursui 2 154,50 JPY, tai atitinka 1,67 % dividendų grąžą.
Dividendai mokami kartus per metus.
1,67 % Dividendo grąža | = | 36,00 JPY Dividendas | 2 154,50 JPY akcijų kaina |
|
Ar Alfresa Holdings dividendai yra saugūs?
Alfresa Holdings kasmet didina dividendus jau 5 metus.
Per pastaruosius 10 metus Alfresa Holdings kasmet 2,730 % padidėjo.
Per 5 metų laikotarpį krito išmokos padidėjo −4,784 %.
Analitikai prognozuoja, kad einamaisiais verslo metais Dividendų didinimas bus 2,117%.
Alfresa Holdings Aktienanalyse
Ką daro Alfresa Holdings?
Alfresa Holdings Corp is a Japanese company specializing in the distribution of pharmaceutical and medical devices. It was founded in 2005 through the merger of two other companies, Alfresa Corporation and Nichimen Corporation.
The history of Alfresa Holdings Corp dates back much further. Alfresa Corporation was already established in 1953 as a wholesale company for pharmaceuticals and quickly became one of the largest companies in the industry. Nichimen Corporation, on the other hand, was founded in 1933 and focused on distributing various products, including chemicals and machinery.
The business model of Alfresa Holdings Corp is centered around supplying pharmaceutical products and medical devices to pharmacies, hospitals, and other medical facilities. The company employs thousands of employees and operates a network of warehouses and distribution centers throughout the country.
The company has divided itself into various business segments, including "Pharmaceutical Products," "Medical Devices," "Hospital and Care Facilities," "Logistics and IT Services," and "Health Promotion and Wellness."
Under the "Pharmaceutical Products" segment, Alfresa Holdings Corp offers a wide range of prescription and over-the-counter medications. In addition to supplying pharmacies and hospitals, the company also provides various services, such as support in procuring medications from abroad.
The "Medical Devices" segment focuses on the distribution of medical devices such as ultrasound machines, EKG devices, and imaging systems, as well as the maintenance and repair of medical equipment.
The "Hospital and Care Facilities" segment offers services such as the development and implementation of digital hospital information systems, the creation of data analysis tools, and consulting services.
Under "Logistics and IT Services," Alfresa Holdings Corp offers warehouse and transportation services, as well as IT support.
The "Health Promotion and Wellness" segment provides various products and services to promote health and well-being. These include dietary supplements, health checks, and training programs.
Alfresa Holdings Corp is a significant company in the Japanese healthcare industry and has become an important player in the global market. The company operates in both the wholesale and retail sectors and is heavily involved in research and development of new pharmaceuticals and medical devices. With its wide range of products and services, Alfresa Holdings Corp is a crucial partner for pharmacies, hospitals, and other medical facilities. Overall, the company is a key innovator in the Japanese healthcare industry and contributes to improving the quality of life for people in Japan and around the world. Alfresa Holdings yra viena populiariausių įmonių Eulerpool.com svetainėje.Akcijų taupymo planai siūlo patrauklią galimybę investuotojams ilgalaikėje perspektyvoje kurti turtą. Vienas pagrindinių privalumų yra vadinamasis vidutinės išlaidos efektas: reguliariai investuojant fiksuotą sumą į akcijas arba akcijų fondus, automatiškai perkama daugiau dalinių vertybių popierių, kai kainos yra žemos, ir mažiau – kai jos aukštos. Tai gali lemti palankesnę vidutinę dalies kainą per laiką. Be to, akcijų taupymo planai suteikia galimybę ir smulkiesiems investuotojams patekti į brangias akcijas, nes jie gali dalyvauti jau su mažomis sumomis. Reguliarus investavimas taip pat skatina disciplinuotą investavimo strategiją ir padeda išvengti emociškai pagrįstų sprendimų, pavyzdžiui, impulsyvaus pirkimo ar pardavimo. Be to, investuotojai gauna naudos iš potencialaus akcijų vertės augimo bei iš dividendų, kurie gali būti reinvestuoti, kas sustiprina sudėtinio palūkanų efektą ir taip skatina investuoto kapitalo augimą.